Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Jeffrey Cohen(Cleveland Clinic), Alasdair Coles(University of Cambridge), Douglas L. Arnold(McGill University), Christian Confavreux(Hospices Civils de Lyon), Edward Fox(Central Texas Neurology Consultants), Hans-Peter Hartung(Heinrich Heine University Düsseldorf), Eva Havrdová(Charles University), Krzysztof Selmaj(Medical University of Lodz), Howard L. Weiner(Brigham and Women's Hospital), Elizabeth Fisher(Cleveland Clinic), Vesna Brinar(University Hospital Centre Zagreb), Gavin Giovannoni(Queen Mary University of London), M. Stojanovic(Clinical Centre of Kragujevac), Bella Ertik, Stephen Lake, David Margolin, Michael Panzara, D. A. S. Compston(University of Cambridge)
Cited by 1,196
Abstract
Related Papers
No related papers found
Powered by citation graph analysis